This Congress Hub is accessible to HCPs from around the world and has been reviewed in accordance with our US headquarter policies.
Your Issue Has Been SubmittedClick Here to Let Us Know
You are about to leave the amgencongresses.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.
Learn about the mechanism of action and the potential promise of the BiTE® immuno-oncology platform.
Learn about KRAS and KRAS G12C mutations in cancer.